BRAF and melanoma: The current therapeutic algorithm for stage IV melanoma comprises Targeted Therapy for patients positive to BRAF V600E mutations, followed by Immune-Checkpoint blockade as a preferential step via PD1 and/or CTLA4 inhibition [2] and chemotherapy.